These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 27752706)

  • 1. [Erratum to: Social medical/public health assessment of bladder cancer after curative and adjuvant therapy].
    Zermann DH; Vahlensieck W; Hoffmann W
    Urologe A; 2016 Sep; ():. PubMed ID: 27752706
    [No Abstract]   [Full Text] [Related]  

  • 2. [Social medical/public health assessment of bladder cancer after curative and adjuvant therapy].
    Zermann DH; Vahlensieck W; Hoffmann W
    Urologe A; 2016 Oct; 55(10):1335-1338. PubMed ID: 27287241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follow-up care of 12 months of patients with bladder cancer in Spain: A multicenter prospective cohort study.
    Bonfill X; Martinez-Zapata MJ; Barrionuevo-Rosas L; Vernooij RW; Sánchez MJ; Morales-Suárez-Varela M; De la Cruz J; Emparanza JI; Ferrer M; Pijoan JI; Palou J; Frances A; Madrid E; Coscia C; Zamora J;
    Medicine (Baltimore); 2022 Oct; 101(42):e31175. PubMed ID: 36281169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum: Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection: Erratum.
    Medicine (Baltimore); 2016 Apr; 95(15):e973b. PubMed ID: 31265562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
    Uchida K; Takeshima H; Kikuchi K; Shimazui T; Miyanaga N; Kawai K; Akaza H; Tsuchiya A; Noguchi R; Hattori K; Manabe F; Matsuki K; Suzuki R; Ishikawa S; Kondo F; Kobayashi T; Koiso K
    Gan To Kagaku Ryoho; 1998 Jul; 25(8):1179-87. PubMed ID: 9679581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant radiation therapy in gall bladder cancers: 10 years experience at Tata Memorial Hospital.
    Mahantshetty UM; Palled SR; Engineer R; Homkar G; Shrivastava SK; Shukla PJ
    J Cancer Res Ther; 2006; 2(2):52-6. PubMed ID: 17998675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic overview of chemotherapy effects in urothelial bladder cancer.
    Nilsson S; Ragnhammar P; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):371-90. PubMed ID: 11441942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial.
    Mitin T; Hunt D; Shipley WU; Kaufman DS; Uzzo R; Wu CL; Buyyounouski MK; Sandler H; Zietman AL
    Lancet Oncol; 2013 Aug; 14(9):863-72. PubMed ID: 23823157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of muscle-invasive bladder cancer in the elderly.
    Rose TL; Milowsky MI
    Curr Opin Urol; 2015 Sep; 25(5):459-67. PubMed ID: 26075567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining optimal therapy for muscle invasive bladder cancer.
    Herr HW; Dotan Z; Donat SM; Bajorin DF
    J Urol; 2007 Feb; 177(2):437-43. PubMed ID: 17222605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum to: Baumann BC, Bosch WR, Bahl A, et al. Development and validation of consensus contouring guidelines for adjuvant radiation therapy for bladder cancer after radical cystectomy. Int J Radiat Oncol Biol Phys 2016;96:78-86.
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1129. PubMed ID: 27869092
    [No Abstract]   [Full Text] [Related]  

  • 12. Carbon Ion Radiotherapy
    Yamamoto N; Oshima T; Kawahara S; Takahashi D; Kamioka Y; Murakawa M; Katoh H; Ueno M; Morinaga S
    Anticancer Res; 2023 Feb; 43(2):809-815. PubMed ID: 36697091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Symptoms of hormonal therapy and social support: Is there a connection? Comparison of symptom severity, symptom interference and social support among breast cancer patients receiving and not receiving adjuvant hormonal treatment.
    Ochayon L; Tunin R; Yoselis A; Kadmon I
    Eur J Oncol Nurs; 2015 Jun; 19(3):260-7. PubMed ID: 25529935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study Protocol of the Bladder Adjuvant RadioTherapy (BART) Trial: A Randomised Phase III Trial of Adjuvant Radiotherapy Following Cystectomy in Bladder Cancer.
    Murthy V; Maitre P; Singh M; Pal M; Arora A; Pujari L; Kapoor A; Pandey H; Sharma R; Gudipudi D; Joshi A; Prabhash K; Noronha V; Menon S; Mehta P; Bakshi G; Prakash G
    Clin Oncol (R Coll Radiol); 2023 Sep; 35(9):e506-e515. PubMed ID: 37208232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant versus Adjuvant Chemotherapy in Patients with Resectable Muscle-Invasive Bladder Cancer.
    Sawasdee A; Tanthanuch M; Bejrananda T
    Asian Pac J Cancer Prev; 2022 Nov; 23(11):3641-3647. PubMed ID: 36444575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eligibility and Radiologic Assessment in Adjuvant Clinical Trials in Bladder Cancer.
    Apolo AB; Milowsky MI; Kim L; Inman BA; Kamat AM; Steinberg G; Bagheri M; Krishnasamy VP; Marko J; Dinney CP; Bangs R; Sweis RF; Maher VE; Ibrahim A; Liu K; Werntz R; Cross F; Beaver JA; Singh H; Pazdur R; Blumenthal GM; Lerner SP; Bajorin DF; Rosenberg JE; Agrawal S
    JAMA Oncol; 2019 Dec; 5(12):1790-1798. PubMed ID: 31670753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant therapy in different risk-groups of patients with superficial bladder cancer.
    Startsev V; Pouline I
    Arch Ital Urol Androl; 2005 Jun; 77(2):93-8. PubMed ID: 16146269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer.
    Chrouser K; Leibovich B; Bergstralh E; Zincke H; Blute M
    J Urol; 2005 Jul; 174(1):107-10; discussion 110-1. PubMed ID: 15947588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis.
    Yang J; Liang H; Hu K; Xiong Z; Cao M; Zhong Z; Yao Z; Deng M
    Cancer Cell Int; 2021 Feb; 21(1):92. PubMed ID: 33549093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic effects of adjuvant chemotherapy after neoadjuvant chemotherapy for locally advanced muscle-invasive bladder cancer.
    Omura M; Kikuchi E; Shigeta K; Ogihara K; Hakozaki K; Hara S; Shirotake S; Ide H; Yoshimine S; Ohigashi T; Mizuno R; Oya M
    Jpn J Clin Oncol; 2022 Apr; 52(4):388-396. PubMed ID: 35106598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.